Home
/
ACCENDRA HEALTH INC/VA/
/
Financials
/
Quarterly
ACCENDRA HEALTH INC/VA/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ACCENDRA HEALTH INC/VA/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$697.26M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$681.92M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$2.63B
May 8, 2025
Q3
2025
Sep 30, 2024
$686.85M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$660.40M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$2.61B
May 8, 2025
Q3
2024
Sep 30, 2023
$2.59B
Nov 4, 2024
Q2
2024
Jun 30, 2023
$2.56B
Aug 2, 2024
Q1
2024
Mar 31, 2023
$2.52B
May 3, 2024
Q3
2023
Sep 30, 2022
$2.50B
Nov 3, 2023
Q2
2023
Jun 30, 2022
$2.50B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$2.41B
May 5, 2023
Q3
2022
Sep 30, 2021
$2.50B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$2.49B
Aug 3, 2022
Q1
2022
Mar 31, 2021
$2.33B
May 4, 2022
Q3
2021
Sep 30, 2020
$2.19B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$1.81B
Aug 3, 2021
Q1
2021
Mar 31, 2020
$2.12B
May 5, 2021
Q3
2020
Sep 30, 2019
$2.29B
Nov 3, 2020
Q2
2020
Jun 30, 2019
$2.38B
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$2.46B
Aug 8, 2018
Q1
2018
Mar 31, 2018
$2.37B
May 10, 2018
Q3
2017
Sep 30, 2017
$2.33B
Nov 2, 2017
Q2
2017
Jun 30, 2017
$2.27B
Aug 2, 2017
Q1
2017
Mar 31, 2017
$2.33B
May 3, 2017
Q3
2016
Sep 30, 2016
$2.42B
Nov 2, 2016
Q2
2016
Jun 30, 2016
$2.48B
Aug 3, 2016
Q1
2016
Mar 31, 2016
$2.46B
May 4, 2016
Q3
2015
Sep 30, 2015
$2.47B
Oct 28, 2015
Q2
2016
Jun 30, 2015
$2.42B
Aug 3, 2016
Q1
2016
Mar 31, 2015
$2.39B
May 4, 2016
Q3
2015
Sep 30, 2014
$2.39B
Oct 28, 2015
Q2
2014
Jun 30, 2014
$2.31B
Jul 30, 2014
Q1
2014
Mar 31, 2014
$2.26B
May 1, 2014
Q3
2013
Sep 30, 2013
$2.30B
Nov 7, 2013
Q2
2013
Jun 30, 2013
$2.27B
Aug 2, 2013
Q1
2013
Mar 31, 2013
$2.28B
May 3, 2013
Q3
2012
Sep 30, 2012
$2.18B
Nov 2, 2012
Q2
2012
Jun 30, 2012
$2.19B
Jul 27, 2012
Q1
2012
Mar 31, 2012
$2.22B
Apr 27, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($150.28M)
Oct 31, 2025
Q2
2025
Jun 30, 2025
($869.06M)
Aug 11, 2025
Q3
2025
Jun 30, 2025
($869.06M)
Oct 31, 2025
Q2
2025
Mar 31, 2025
($24.98M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($24.98M)
Oct 31, 2025
Q1
2025
Mar 31, 2025
($24.98M)
May 8, 2025
Q3
2025
Sep 30, 2024
($12.77M)
Oct 31, 2025
Q2
2025
Jun 30, 2024
($31.91M)
Aug 11, 2025
Q3
2025
Jun 30, 2024
($31.91M)
Oct 31, 2025
Q2
2025
Mar 31, 2024
($21.89M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($21.89M)
May 8, 2025
Q3
2025
Mar 31, 2024
($21.89M)
Oct 31, 2025
Q3
2024
Sep 30, 2023
($6.43M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($28.24M)
Aug 2, 2024
Q3
2024
Jun 30, 2023
($28.24M)
Nov 4, 2024
Q1
2024
Mar 31, 2023
($24.42M)
May 3, 2024
Q3
2024
Mar 31, 2023
($24.42M)
Nov 4, 2024
Q2
2024
Mar 31, 2023
($24.42M)
Aug 2, 2024
Q3
2023
Sep 30, 2022
$12.50M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$28.60M
Aug 4, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$26.47M
Oct 31, 2025
Q2
2025
Jun 30, 2025
($39.71M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
$124.0K
May 8, 2025
Q3
2025
Sep 30, 2024
$31.08M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$16.92M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$9.70M
May 8, 2025
Q3
2024
Sep 30, 2023
$23.84M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$10.84M
Aug 2, 2024
Q1
2024
Mar 31, 2023
$9.81M
May 3, 2024
Q3
2023
Sep 30, 2022
$60.25M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$75.09M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$61.06M
May 5, 2023
Q3
2022
Sep 30, 2021
$62.88M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$96.88M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$146.69M
May 4, 2022
Q3
2021
Sep 30, 2020
$75.55M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$22.20M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$10.76M
May 5, 2021
Q3
2020
Sep 30, 2019
$26.11M
Nov 3, 2020
Q2
2020
Jun 30, 2019
$15.90M
Aug 5, 2020